Cash Oxycodone Prescription With Multiple Recent PMP Fills
On a Friday afternoon, a 34-year-old man presents to an independent pharmacy in Buffalo with a new electronic prescription for oxycodone 30 mg tablets, #120, one tablet every six hours as needed for pain. The prescriber is a pain clinic 300 miles away in New York City. The patient is paying cash, says he just moved to the area, and has no prior records at this pharmacy. The pharmacist checks the New York PMP registry and finds three fills in the past 30 days: #90 from a Rochester pharmacy 10 days ago, #90 from a Syracuse pharmacy 24 days ago, and #60 from a Bronx pharmacy 27 days ago, written by three different prescribers. The patient explains that his previous pharmacy “lost” his last prescription and that he needs this fill today. The pharmacy closes in 45 minutes, and the prescriber’s office is not answering the phone.
1. What does New York law require the pharmacist to do with the PMP registry before dispensing this prescription, and how does the registry result affect the analysis?
Read the worked answer
New York requires a pharmacist to consult the PMP registry before dispensing a Schedule II, III, or IV controlled substance. The check is mandatory, not discretionary, and the pharmacist must review the results as part of the corresponding-responsibility analysis. Here the registry does not merely confirm prior therapy; it reveals a pattern that requires resolution: three different prescribers, three different pharmacies, fills at 10, 24, and 27 days, a cash payment, a long distance between prescriber and pharmacy, and a patient with no local record. Those are classic red flags for diversion or duplicative prescribing. The registry result does not by itself make the prescription invalid, and the pharmacist may not refuse solely because a PMP hit exists. It does mean the pharmacist cannot simply dispense on the patient’s explanation. The pharmacist must reconcile the PMP data with the prescription and the patient’s account before exercising professional judgment.
2. Can the pharmacist dispense now? Outline the steps the pharmacist should take and the documentation that should be created.
Read the worked answer
On the current information, the pharmacist should not dispense yet. The pharmacist should verify the patient’s identity with a government-issued photo ID, contact the prescriber to confirm the diagnosis, the intended dose, and whether the prescriber knows about the other prescribers and fills, and ask the patient directly about the other prescriptions. The pharmacist should also determine whether any of the earlier prescriptions are still active and whether the patient is obtaining duplicate therapy. All attempts, including the time of calls, the persons spoken with, and the information received, should be documented. If the prescriber cannot be reached and the red flags remain unresolved, the pharmacist may decline to fill. For an electronic prescription, the pharmacist should notify the prescriber that the prescription was not filled and explain the reason; the pharmacist should not confiscate the patient’s identification or accuse the patient of a crime. If the pharmacist ultimately dispenses, the pharmacist should counsel on safe use, storage, and disposal and offer naloxone.
3. The prescriber calls back and confirms that the patient is enrolled in a pain-management program and that the other prescriptions came from covering physicians. Does that end the inquiry?
Read the worked answer
No. A prescriber’s confirmation is important, but it does not automatically eliminate the pharmacist’s corresponding responsibility. The pharmacist should confirm that the prescriber is currently licensed and DEA-registered, that the prescriber actually knows about the other prescribers and the recent fills, and that the prescriber believes the total opioid exposure is medically appropriate. The pharmacist should also verify that the patient is not receiving overlapping prescriptions from covering physicians without coordination and should document the prescriber’s explanation. If the explanation is coherent and the prescription is otherwise valid, the pharmacist may dispense one fill, report the dispensing to the PMP by the next business day, and document the resolution of the red flags. If the explanation is incomplete or inconsistent, the pharmacist may still refuse. The key is that the pharmacist must make and document an independent professional judgment, not merely rely on the prescriber’s authorization.